Effects of vitamin E ingestion on plasma and urinary risk factors for calcium oxalate urolithiasis in two population groups having different stone-risk profiles: evidence of different physiological handling mechanisms

Theka, Takalani; Rodgers, Allen; Lewandowski, Sonja; Webber, Dawn; Allie-Hamdulay, Shameez
April 2012
Urological Research;Apr2012, Vol. 40 Issue 2, p113
Academic Journal
It has been demonstrated that vitamin E supplementation reduces calciuria and oxaluria and that it may also prevent oxalate-mediated peroxidative injury, all of which reduce the risk of calcium oxalate urolithiasis. In view of the significant difference in stone occurrence in black (B) and white (W) South Africans, we undertook to investigate the effects of vitamin E supplementation in subjects from these two groups. Five healthy males from each group ingested one capsule (400 IU) of vitamin E daily for 60 days. Blood and 24 h urine samples were collected at baseline and on day 60; 24 h dietary questionnaires were simultaneously completed. Urine composition was determined by routine analyses. Urinary and plasma TBARS were determined using a commercially available assay kit while plasma vitamin E was determined by reverse phase HPLC. Plasma vitamin E increased significantly in W but not in B. Urinary and plasma TBARS did not increase in either group. Urinary citrate increased significantly in both groups but the percentage increase in W (169%) was greater than that in B (82%). No other urinary parameter changed significantly. The increase in plasma vitamin E in W but not in B suggests either that the mechanism by which it is packaged into chylomicrons, which are secreted into the systemic circulation, is suppressed in the latter group or that it is differentially absorbed in the two groups. Similarly, to explain the greater increase in citraturia in W compared to B, we speculate that inhibition of lipogenesis of arachidonic acid by vitamin E, ultimately leading to an increase in citraturia, occurs to a lesser extent in B than in W.


Related Articles

  • The construction of an oxalate-degrading intestinal stem cell population in mice: a potential new treatment option for patients with calcium oxalate calculus. Chen, Zhiqiang; Liu, Guanlin; Ye, Zhangqun; Kong, Debo; Yao, Lingfang; Guo, Hui; Yang, Weimin; Yu, Xiao // Urological Research;Apr2012, Vol. 40 Issue 2, p131 

    About 80% of all urological stones are calcium oxalate, mainly caused by idiopathic hyperoxaluria (IH). The increased absorption of oxalate from the intestine is the major factor underlying IH. The continuous self-renewal of the intestinal epithelium is due to the vigorous proliferation and...

  • Improved methodology to induce hyperoxaluria without treatment using hydroxyproline. Wiessner, John; Garrett, Michael; Hung, Linda; Wille, David; Mandel, Neil // Urological Research;Oct2011, Vol. 39 Issue 5, p373 

    The use of hydroxyproline (HP) to generate hyperoxaluria in the rat is a problem because it is impossible to separate the effect of oxalate on renal injury from the effects of HP and the large array of metabolic intermediates formed when HP is converted to oxalate. Previously, the Dahl...

  • Spontaneous urinary calcium oxalate crystallization in hypercalciuric children. Porowski, Tadeusz; Konstantynowicz, Jerzy; Zoch-Zwierz, Walentyna; Kirejczyk, Jan; Taranta-Janusz, Katarzyna; Korzeniecka-Kozerska, Agata // Pediatric Nephrology;Sep2009, Vol. 24 Issue 9, p1705 

    Idiopathic hypercalciuria is the most important predisposing risk factor for calcium oxalate (CaOx) renal stone formation. We assessed the associations between spontaneous CaOx crystallization based on the Bonn Risk Index (BRI), urinary pH, calciuria, oxaluria, and citraturia in 140 Caucasian...

  • The riddle of kidney stone disease: lessons from Africa. Rodgers, Allen // Urological Research;Apr2006, Vol. 34 Issue 2, p92 

    Urolithiasis has not been extensively researched in the African continent due to a general lack of facilities and resources. Consideration of the few published papers indicates that there are some regions where the occurrence of stones is extremely rare. South Africa is unique in two respects....

  • Primary hyperoxaluria type 2. Kemper, M. J.; Conrad, S.; Müller-Wiefel, D. E. // European Journal of Pediatrics;1997, Vol. 156 Issue 7, p509 

    Primary hyperoxaluria type 2 (PH2) is a rare disease with only 24 patients reported in the literature so far. It should be considered in any patient presenting with urolithiasis or nephrocalcinosis due to hyperoxaluria. The metabolic defect is deficiency of d-glycerate dehydrogenase/glyoxylate...

  • Interaction of a complexing agent with urolith as the basis for efficient little-invasive therapy of phosphaturia. Kustov, A.; Berezin, B.; Strel’nikov, A.; Shevyrin, A.; Trostin, V. // Doklady Physical Chemistry;Sep2009, Vol. 428 Issue 1, p175 

    The article examines the solubility of phosphate in complexing agents solutions with uroliths in sodium citrate. It explores the litholysis methods of residual concrements following the solubilities of urolithiasis, a calculi that are made of calcium oxalate and calcium phosphate that affects...

  • Supersaturation and renal precipitation: the key to stone formation? Kavanagh, John // Urological Research;Apr2006, Vol. 34 Issue 2, p81 

    The article examines the roles of supersaturation and renal precipitation in urinary stone formation. Stone formation is a result of excessive supersaturation. Supersaturation is the chemical force that enables crystals to form, grow and aggregate. Calcium stones can be grown in vitro and in...

  • In vitro calcium oxalate crystallisation methods. Kavanagh, John // Urological Research;Apr2006, Vol. 34 Issue 2, p139 

    In vitro calcium oxalate crystallisation has been, and will continue to be, of fundamental importance to urolithiasis research. Many different methods have been employed which differ qualitatively and quantitatively in the extent that they reproduce aspects of the renal system or in their...

  • Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth. Webber, Dawn; Rodgers, Allen L.; Sturrock, Edward D. // Urological Research;Dec2007, Vol. 35 Issue 6, p277 

    Urinary glycoproteins play an important role in the modulation of calcium oxalate crystallisation. In several cases, this has been attributed to glycosylation of the proteins as evidenced by urinary prothrombin fragment 1 where there is a correlation between sialylation and calcium oxalate...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics